NCT00487500

Brief Summary

This study will compare four types of electroconvulsive therapy to determine if they differ in their effects on mood, thinking, brain activity, and biochemistry in people with major depressive disorder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for phase_4 depression

Timeline
Completed

Started Dec 1998

Longer than P75 for phase_4 depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 1998

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2002

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2005

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

June 15, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 18, 2007

Completed
Last Updated

August 18, 2014

Status Verified

June 1, 2007

Enrollment Period

4 years

First QC Date

June 15, 2007

Last Update Submit

August 15, 2014

Conditions

Keywords

Major Depressive DisorderElectroconvulsive Therapy

Outcome Measures

Primary Outcomes (2)

  • Short-term antidepressant efficacy

    Primary outcome reflected change in HRSD depression symptom scores.

    Measured immediately post-treatment and 2, 4, and 6 months post-treatment

  • Specific acute, short-term, and long-term objective and subjective cognitive outcome measures (e.g., autobiographical amnesia, global self-rating of amnesia)

    Specific neuropsychological measures were preselected as primary in safety analyses

    Measured immediately post-treatment and 2, 4, and 6 months post-treatment

Secondary Outcomes (3)

  • Antidepressant efficacy

    Measured immediately post-treatment and 2, 4, and 6 months post-treatment

  • Assessments of functional outcomes

    Measured immediately post-treatment and 2, 4, and 6 months post-treatment

  • Memory, non-memory, and executive functions (acute, short-term, and long-term measures)

    Measured immediately post-treatment and 2, 4, and 6 months post-treatment

Study Arms (4)

Ultrabrief, Right Unilateral ECT

EXPERIMENTAL

Right unilateral ECT administered with an ultrabrief pulse width (0.3 ms), at a dose 6 times the initial seizure threshold

Device: Electroconvulsive Therapy (ECT)

Ultrabrief, Bilateral ECT (2.5 X ST)

EXPERIMENTAL

Bilateral (frontotemporal) ECT with an ultrabrief pulse width with dosage 2.5 times the initial seizure threshold

Device: Electroconvulsive Therapy (ECT)

Brief Pulse, Right Unilateral ECT

ACTIVE COMPARATOR

Right unilateral ECT, with a standard brief pulse (1.5 ms), with dosage 6 times the initial seizure threshold

Device: Electroconvulsive Therapy (ECT)

Brief Pulse, Bilateral ECT

ACTIVE COMPARATOR

Bilateral (frontotemporal) ECT with a standard brief pulse (1.5 ms), with dosage 2.5 times the initial seizure threshold

Device: Electroconvulsive Therapy (ECT)

Interventions

Electroconvulsive therapy involves applying a small electrical charge to the scalp while the patient is anesthetized and provoking a short-lasting generalized seizure

Also known as: shock therapy
Brief Pulse, Bilateral ECTBrief Pulse, Right Unilateral ECTUltrabrief, Bilateral ECT (2.5 X ST)Ultrabrief, Right Unilateral ECT

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of major depressive disorder
  • Pretreatment score of at least 18 on the Hamilton Rating Scale for Depression
  • Able to tolerate psychotropic washout and no psychotropic medication, other than lorazepam (up to 3 mg/d PRN), during the study
  • Recommended to receive ECT

You may not qualify if:

  • History of schizophrenia, schizoaffective disorder, other functional psychosis, or rapid cycling bipolar disorder
  • Secondary diagnosis of a delirium, dementia, or amnestic disorder, or epilepsy
  • Pregnant
  • History of neurological illness other than conditions associated with psychotropic exposure (e.g., tardive dyskinesia)
  • History of alcohol or substance abuse within the year prior to study entry
  • History of ECT within the 6 months prior to study entry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York State Psychiatric Institute

New York, New York, 10032, United States

Location

Related Publications (2)

  • Sackeim, H. A.: The convulsant and anticonvulsant properties of electroconvulsive therapy: towards a focal form of brain stimulation. Clinical Neuroscience Review, 2004, 4:39-57.

    RESULT
  • Sackeim HA, Prudic J, Nobler MS, Fitzsimons L, Lisanby SH, Payne N, Berman RM, Brakemeier EL, Perera T, Devanand DP. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul. 2008 Apr;1(2):71-83. doi: 10.1016/j.brs.2008.03.001.

MeSH Terms

Conditions

DepressionDepressive Disorder, Major

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorDepressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Harold A. Sackeim, PhD

    New York State Psychiatric Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2007

First Posted

June 18, 2007

Study Start

December 1, 1998

Primary Completion

December 1, 2002

Study Completion

May 1, 2005

Last Updated

August 18, 2014

Record last verified: 2007-06

Locations